Improving patient recruitment to randomised trials can be cost-effective: A case-study of dexamethasone from the RECOVERY trial
Slow recruitment to randomised trials can have huge implications for healthcare systems as a result of not introducing a more cost-effective treatment earlier through faster patient recruitment.
Authors
- Athanasios Gkekas (ORCID: https://orcid.org/0000-0003-4357-9043)
- Sarah Ronaldson (ORCID: https://orcid.org/0000-0001-8321-786X)
- David Torgerson (ORCID: https://orcid.org/0000-0002-1667-4275)
- Adwoa Parker
Institutions
- Leeds and York Partnership NHS Foundation Trust (GB)
- University of York (GB)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1371/journal.pone.0314593
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of York